Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prevalence of Human Papillomavirus Infection Among Women in Concordia, Argentina:

Prevalence of Human Papillomavirus Infection Among Women in Concordia, Argentina: Prevalence of Human Papillomavirus Infection Among Women in Concordia, Argentina: A Population-Based Study †a ‡ ELENA MATOS, PHD,* DORA LORIA, PHD,* GUSTAVO M. AMESTOY, MD, PHD, LILY HERRERA, MD, ‡ ‡ ‡ § MIGUEL A. PRINCE, MD, JUAN MORENO, MD, CRISTINA KRUNFLY, MD, A. J. C. VAN DEN BRULE, PHD, CHRIS J. L. M. MEIJER, MD, NUBIA MUN ˜ OZ, MD, MPH, ROLANDO HERRERO, MD, PHD, AND PROYECTO CONCORDIA COLLABORATIVE GROUP Background: Preparing for HPV vaccine programs, studies are From the *Instituto Roffo, University of Buenos Aires and needed of HPV infection in different populations. CONICET, and CEMIC and Austral University Hospital, Buenos Goal: The goal was to evaluate HPV prevalence and determinants Aires, Argentina; Hospital Felipe Heras, Concordia, Entre Rı´os, in Concordia, Argentina. Argentina; Free University Hospital, Amsterdam, The Netherlands; Study Design: A stratified random sample of 1786 households was and IARC, Lyon, France and Proyecto Epidemiolo ´ gico obtained. Consenting women aged >15 years were interviewed and Guanacaste, San Jose ´ , Costa Rica underwent examination, including colposcopy. Cells were collected for a Papanicolaou smear and HPV DNA testing with GP5/6 primer– mediated PCR-EIA. Results: PCR was performed on specimens from 987 women. Preva- lence among women http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Sexually Transmitted Diseases Wolters Kluwer Health

Loading next page...
 
/lp/wolters-kluwer-health/prevalence-of-human-papillomavirus-infection-among-women-in-concordia-K3OFn06JdL

References (28)

ISSN
0148-5717
eISSN
1537-4521
DOI
10.1097/01.OLQ.0000085181.25063.6C
pmid
12897679
Publisher site
See Article on Publisher Site

Abstract

Prevalence of Human Papillomavirus Infection Among Women in Concordia, Argentina: A Population-Based Study †a ‡ ELENA MATOS, PHD,* DORA LORIA, PHD,* GUSTAVO M. AMESTOY, MD, PHD, LILY HERRERA, MD, ‡ ‡ ‡ § MIGUEL A. PRINCE, MD, JUAN MORENO, MD, CRISTINA KRUNFLY, MD, A. J. C. VAN DEN BRULE, PHD, CHRIS J. L. M. MEIJER, MD, NUBIA MUN ˜ OZ, MD, MPH, ROLANDO HERRERO, MD, PHD, AND PROYECTO CONCORDIA COLLABORATIVE GROUP Background: Preparing for HPV vaccine programs, studies are From the *Instituto Roffo, University of Buenos Aires and needed of HPV infection in different populations. CONICET, and CEMIC and Austral University Hospital, Buenos Goal: The goal was to evaluate HPV prevalence and determinants Aires, Argentina; Hospital Felipe Heras, Concordia, Entre Rı´os, in Concordia, Argentina. Argentina; Free University Hospital, Amsterdam, The Netherlands; Study Design: A stratified random sample of 1786 households was and IARC, Lyon, France and Proyecto Epidemiolo ´ gico obtained. Consenting women aged >15 years were interviewed and Guanacaste, San Jose ´ , Costa Rica underwent examination, including colposcopy. Cells were collected for a Papanicolaou smear and HPV DNA testing with GP5/6 primer– mediated PCR-EIA. Results: PCR was performed on specimens from 987 women. Preva- lence among women

Journal

Sexually Transmitted DiseasesWolters Kluwer Health

Published: Aug 1, 2003

There are no references for this article.